Ascent Solar Technologies, Inc. Common Stock (ASTI) 10-Q 6 Aug 24 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Aug. 06, 2024
Cover [Abstract]
Entity Registrant Name	Ascent Solar Technologies, Inc.
Entity Central Index Key	0001350102
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Document Type	10-Q
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity File Number	001-32919
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		102,344,843
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-3672603
Entity Address, Address Line One	12300 Grant Street
Entity Address, City or Town	Thornton
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80241
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
City Area Code	720
Local Phone Number	872-5000
Title of 12(b) Security	Common
Trading Symbol	ASTI
Security Exchange Name	NASDAQ

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 5,785,058	$ 1,048,733
Trade receivables, net of allowance of $0 and $0, respectively	22,324	0
Inventories, net	460,856	447,496
Prepaid and other current assets	149,451	39,279
Total current assets	6,417,689	1,535,508
Property, Plant and Equipment:	19,679,497	21,177,892
Accumulated depreciation	(19,412,704)	(20,131,008)
Property, Plant and Equipment, net	266,793	1,046,884
Other Assets:
Operating lease right-of-use assets, net	2,129,854	2,364,672
Patents, net of accumulated amortization of $178,704 and $173,387 respectively	48,661	53,978
Equity method investment	64,931	68,867
Other non-current assets	1,228,399	1,228,797
Total other assets	3,471,845	3,716,314
Total Assets	10,156,327	6,298,706
Current Liabilities:
Accounts payable	657,140	579,237
Related party payables	5,769	4,231
Accrued expenses	1,096,959	1,354,159
Accrued payroll	238,834	160,477
Accrued professional services fees	161,258	849,282
Accrued interest	638,633	628,145
Current portion of operating lease liability	533,503	491,440
Conversions payable		1,089,160
Current portion of convertible notes, net		354,936
Bridge loan	637,751
Other payable	250,000	250,000
Total current liabilities	4,219,847	5,761,067
Long-Term Liabilities:
Non-current operating lease liabilities	1,762,575	2,043,025
Accrued warranty liability	21,225	21,225
Total liabilities	6,003,647	7,825,317
Commitments and contingencies (Note 17)
Stockholders’ Equity (Deficit):
Series A preferred stock, $.0001 par value; 750,000 shares authorized; 48,100 and 48,100 shares issued and outstanding, respectively ($923,386 and $899,069 Liquidation Preference, respectively)	5	5
Common stock, $0.0001 par value, 500,000,000 authorized; 98,825,076 and 3,583,846 shares issued and outstanding, respectively	9,882	358
Additional paid in capital	492,598,096	480,942,526
Accumulated deficit	(488,462,005)	(482,478,436)
Accumulated other comprehensive loss	6,702	8,936
Total stockholders’ equity (deficit)	4,152,680	(1,526,611)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 10,156,327	$ 6,298,706

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Allowance for doubtful accounts	$ 0	$ 0
Patents, amortization	$ 178,704	$ 173,387
Preferred stock, par value (in dollars per share)	$ 0.0001
Preferred stock, shares authorized (in shares)	25,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	98,825,076	3,583,846
Common stock, shares outstanding (in shares)	98,825,076	3,583,846
Series A Preferred Stock
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	750,000	750,000
Preferred stock, shares issued (in shares)	48,100	48,100
Preferred stock, shares outstanding (in shares)	48,100	48,100
Preferred stock, liquidation preference	$ 923,386	$ 899,069

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total Revenues	$ 27,743	$ 101,301	$ 33,343	$ 225,526
Costs and Expenses
Costs of revenue	61,524	666,269	70,912	1,128,064
Research, development and manufacturing operations	506,001	822,321	1,113,231	2,488,016
Selling, general and administrative	1,611,438	1,178,832	2,671,489	2,770,652
Share-based compensation	185,702	560,861	444,928	1,965,311
Depreciation and amortization	18,651	24,443	39,408	50,224
Impairment loss			524,481
Total Costs and Expenses	2,383,316	3,252,726	4,864,449	8,402,267
Loss from Operations	(2,355,573)	(3,151,425)	(4,831,106)	(8,176,741)
Other Income/(Expense)
Other income/(expense), net	(37,988)		26,333	10,000
Warrant settlement (Note 15)	(743,459)		(743,459)
Interest expense	(307,081)	(761,877)	(433,635)	(1,829,913)
Total Other Income/(Expense)	(1,088,528)	(761,877)	(1,150,761)	(1,819,913)
Income/(Loss) on Equity Method Investments	(1,726)	(170)	(1,702)	(170)
Net Income/(Loss)	$ (3,445,827)	$ (3,913,472)	$ (5,983,569)	$ (9,996,824)
Net Income/(Loss) Per Share (Basic)	$ (0.07)	$ (66.4)	$ (0.21)	$ (105.08)
Net Income/(Loss) Per Share (Diluted)	$ (0.07)	$ (66.4)	$ (0.21)	$ (105.08)
Weighted Average Common Shares Outstanding (Basic)	50,995,733	234,439	27,876,905	206,041
Weighted Average Common Shares Outstanding (Diluted)	50,995,733	234,439	27,876,905	206,041
Other Comprehensive Income/(Loss)
Foreign currency translation gain/(loss)	$ (522)	$ (4,836)	$ (2,234)	$ 1,870
Net Comprehensive Income/(Loss)	(3,446,349)	(3,918,308)	(5,985,803)	(9,994,954)
Products
Total Revenues	$ 27,743	86,385	$ 33,343	185,610
Milestone and engineering
Total Revenues		$ 14,916		$ 39,916

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	L1 Convertible Note	Sabby Note	Preferred Stock Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Preferred Stock Series A Preferred Stock	Preferred Stock Series 1B Preferred Stock	Common Stock	Common Stock L1 Convertible Note	Common Stock Sabby Note	Additional Paid-In Capital	Additional Paid-In Capital L1 Convertible Note	Additional Paid-In Capital Sabby Note	Accumulated Deficit	Other Accumulated Comprehensive Loss
Beginning balance at Dec. 31, 2022	$ 899,298				$ 5		$ 26			$ 448,343,153			$ (447,427,862)	$ (16,024)
Beginning balance (in shares) at Dec. 31, 2022					48,100		259,323
Conversion of shares		$ 508,740	$ 1,083,718					$ 1	$ 1		$ 508,739	$ 1,083,717
Conversion of shares (in shares)								7,200	10,255
Share-based compensation	1,404,450									1,404,450
Net Income (Loss)	(6,083,352)												(6,083,352)
Foreign Currency Translation Loss	6,706													6,706
Ending balance at Mar. 31, 2023	(2,180,440)				$ 5		$ 28			451,340,059			(453,511,214)	(9,318)
Ending balance (in shares) at Mar. 31, 2023					48,100		276,778
Beginning balance at Dec. 31, 2022	899,298				$ 5		$ 26			448,343,153			(447,427,862)	(16,024)
Beginning balance (in shares) at Dec. 31, 2022					48,100		259,323
Net Income (Loss)	(9,996,824)
Ending balance at Jun. 30, 2023	(2,793,128)				$ 5		$ 37			466,299,656			(469,078,672)	(14,154)
Ending balance (in shares) at Jun. 30, 2023					48,100	900	368,907
Beginning balance at Mar. 31, 2023	(2,180,440)				$ 5		$ 28			451,340,059			(453,511,214)	(9,318)
Beginning balance (in shares) at Mar. 31, 2023					48,100		276,778
Conversion of shares		732,078	$ 1,039,931					$ 4	$ 5		732,074	$ 1,039,926
Conversion of shares (in shares)								37,929	52,775
Share-based compensation	560,861									560,861
Proceeds from issuance of Series 1B Preferred Stock	900,000									900,000
Proceeds from issuance of Series 1B Preferred Stock (in shares)						900
Preferred Stock issuance cost	(20,000)									(20,000)
Common stock issued for services	92,750									92,750
Common stock issued for services (in shares)							1,425
Down round deemed dividend										11,653,986			(11,653,986)
Net Income (Loss)	(3,913,472)												(3,913,472)
Foreign Currency Translation Loss	(4,836)													(4,836)
Ending balance at Jun. 30, 2023	(2,793,128)				$ 5		$ 37			466,299,656			(469,078,672)	(14,154)
Ending balance (in shares) at Jun. 30, 2023					48,100	900	368,907
Beginning balance at Dec. 31, 2023	(1,526,611)			$ 5			$ 358			480,942,526			(482,478,436)	8,936
Beginning balance (in shares) at Dec. 31, 2023				48,100			3,583,846
Conversion of shares		$ 1,256,692						$ 241			$ 1,256,451
Conversion of shares (in shares)								2,411,788
Exercise of prefunded warrants							$ 72			(72)
Exercise of prefunded warrants (in shares)							715,111
Share-based compensation	259,234									259,234
Net Income (Loss)	(2,537,742)												(2,537,742)
Foreign Currency Translation Loss	(1,712)													(1,712)
Ending balance at Mar. 31, 2024	(2,550,139)				$ 5		$ 671			482,458,139			(485,016,178)	7,224
Ending balance (in shares) at Mar. 31, 2024					48,100		6,710,745
Beginning balance at Dec. 31, 2023	$ (1,526,611)			$ 5			$ 358			480,942,526			(482,478,436)	8,936
Beginning balance (in shares) at Dec. 31, 2023				48,100			3,583,846
Exercise of prefunded warrants (in shares)	21,162,277
Net Income (Loss)	$ (5,983,569)
Ending balance at Jun. 30, 2024	4,152,680				$ 5		$ 9,882			492,598,096			(488,462,005)	6,702
Ending balance (in shares) at Jun. 30, 2024					48,100		98,825,076
Beginning balance at Mar. 31, 2024	(2,550,139)				$ 5		$ 671			482,458,139			(485,016,178)	7,224
Beginning balance (in shares) at Mar. 31, 2024					48,100		6,710,745
Sale of common stock	4,455,240						$ 1,518			4,453,722
Sale of common stock (in shares)							15,179,460
Exercise of prefunded warrants							$ 2,116			(2,116)
Exercise of prefunded warrants (in shares)							21,162,277
Share-based compensation	170,749						$ 8			170,741
Share-based compensation (in shares)							79,951
Proceeds from sale on ATM facility, net of expenses of $[***]	8,341,220						$ 5,534			8,335,686
Proceeds from sale on ATM facility, net of expenses of $[***] (in shares)							55,342,643
Common stock issued to settle liabilities	38,500						$ 35			38,465
Common stock issued to settle liabilities (in shares)							350,000
Warrant repurchase	(3,600,000)									(3,600,000)
Warrant settlement	743,459									743,459
Net Income (Loss)	(3,445,827)												(3,445,827)
Foreign Currency Translation Loss	(522)													(522)
Ending balance at Jun. 30, 2024	$ 4,152,680				$ 5		$ 9,882			$ 492,598,096			$ (488,462,005)	$ 6,702
Ending balance (in shares) at Jun. 30, 2024					48,100		98,825,076

CONDENSED STATEMENTS OF CHANG_2

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)	3 Months Ended
	Jun. 30, 2024 USD ($)
Sale on ATM facility, net of expenses	$ 617,694

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Operating Activities:
Net income/(loss)	$ (3,445,827)	$ (2,537,742)	$ (3,913,472)	$ (6,083,352)	$ (5,983,569)	$ (9,996,824)
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization					39,408	50,224
Share-based compensation					444,924	1,965,311
Stock issued for services					38,500
Stock issued for warrant settlement					743,459
Operating lease asset amortization					234,818	394,638
Amortization of debt discount					64,017	1,542,085
Loss on equity method investment	1,726		170		1,702	170
Inventory reserve expense					(35,915)	83,357
Impairment loss					524,481
Other					(14,941)
Changes in operating assets and liabilities:
Accounts receivable					(22,324)	(13,147)
Inventories					22,555	(146,362)
Prepaid expenses and other current assets					(109,774)	17,330
Accounts payable					77,903	557,146
Related party payable					1,538	(51,971)
Operating lease liabilities					(238,387)	(384,708)
Accrued interest					10,488	113,909
Accrued expenses					(645,348)	(708,984)
Net cash used in operating activities					(4,846,465)	(6,577,826)
Investing Activities:
Payments on purchase of assets						(3,841,373)
Patent activity costs						(8,169)
Net cash used in investing activities						(3,849,542)
Financing Activities:
Proceeds from issuance of Series 1B Preferred Stock						880,000
Proceeds from bridge loans					1,153,750
Repayment of bridge loans					(560,756)
Proceeds from issuance of Common Stock					12,796,460
Warrant repurchase					(3,600,000)
Payment of convertible notes and cash payable					(206,664)	(1,025,423)
Net cash provided by (used in) financing activities					9,582,790	(145,423)
Effect of foreign exchange rate on cash						(4,606)
Net change in cash and cash equivalents					4,736,325	(10,577,397)
Cash and cash equivalents at beginning of period		$ 1,048,733		$ 11,483,018	1,048,733	11,483,018	$ 11,483,018
Cash and cash equivalents at end of period	$ 5,785,058		$ 905,621		5,785,058	905,621	$ 1,048,733
Non-Cash Transactions:
Exercise of prefunded warrants					2,188
Non-cash conversions of convertible notes to equity					1,256,692	3,364,467
Down round deemed dividend						11,653,986
Supplemental disclosure of cash flow information:
Interest					$ 258,000	$ 173,600

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (3,445,827)	$ (2,537,742)	$ (3,913,472)	$ (6,083,352)	$ (5,983,569)	$ (9,996,824)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false

ORGANIZATION

ORGANIZATION	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	NOTE 1. ORGANIZATION Ascent Solar Technologies, Inc. (the “Company") is focusing on integrating its photovoltaic ("PV") products into scalable and high value markets such as agrivoltaics, aerospace, satellites, near earth orbiting vehicles, and fixed wing unmanned aerial vehicles (“UAV”). The value proposition of Ascent’s proprietary solar technology not only aligns with the needs of customers in these industries, but also overcomes many of the obstacles other solar technologies face in these unique markets. Ascent has the capability to design and develop finished products for end users in these areas as well as collaborate with strategic partners to design and develop custom integrated solutions for products like fixed-wing UAVs. Ascent sees significant overlap of the needs of end users across some of these industries and can achieve economies of scale in sourcing, development, and production in commercializing products for these customers.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
BASIS OF PRESENTATION	NOTE 2. BASIS OF PRESENTATION The accompanying, unaudited, condensed financial statements have been derived from the accounting records of the Company as of June 30, 2024, and December 31, 2023, and the results of operations for the three and six months ended June 30, 2024, and 2023. The accompanying, unaudited, condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, these interim financial statements do not include all of the information and footnotes typically found in U.S. GAAP audited annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement have been included. The Condensed Balance Sheet at December 31, 2023, has been derived from the audited financial statements as of that date but does not include all of the information and footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. These condensed financial statements and notes should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Operating results for the three and six months ended June 30, 2024 , are not necessarily indicative of the results that may be expected for the year ending December 31, 2024.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The Company’s significant accounting policies were described in Note 2 to the audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. There have been no significant changes to our accounting policies as of June 30, 2024. Revenue Recognition: Product revenue. The Company recognizes revenue for the sale of PV modules and other equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. For module and other equipment sales contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices, or estimates of such prices, and recognizes the related revenue as control of each individual product is transferred to the customer. During the three months ended June 30, 2024 and 2023, the Company recognized product revenue of $ 27,743 and $ 86,385 , respectively. During the six months ended June 30, 2024 and 2023, the Company recognized product revenue of $ 33,343 and $ 185,610 , respectively. Milestone and engineering revenue. Each milestone and engineering arrangement is a separate performance obligation. The transaction price is estimated using the most likely amount method and revenue is recognized as the performance obligation is satisfied through achieving manufacturing, cost, or engineering targets. During the three months ended June 30, 2024 and 2023, the Company recognized total milestone and engineering revenue of $ 0 and $ 14,916 , respectively. During the six months ended June 30, 2024 and 2023, the Company recognized total milestone and engineering revenue of $ 0 and $ 39,916 , respectively. Government contracts revenue. Revenue from government research and development contracts is generated under terms that are cost plus fee or firm fixed price. The Company generally recognizes this revenue over time using cost-based input methods, which recognizes revenue and gross profit as work is performed based on the relationship between actual costs incurred compared to the total estimated costs of the contract. In applying cost-based input methods of revenue recognition, the Company uses the actual costs incurred relative to the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize. Cost based input methods of revenue recognition are considered a faithful depiction of the Company’s efforts to satisfy long-term government research and development contracts and therefore reflect the performance obligations under such contracts. Costs incurred that do not contribute to satisfying the Company’s performance obligations are excluded from the input methods of revenue recognition as the amounts are not reflective of transferring control under the contract. Costs incurred towards contract completion may include direct costs plus allowable indirect costs and an allocable portion of the fixed fee. If actual and estimated costs to complete a contract indicate a loss, provision is made currently for the loss anticipated on the contract. No government contract revenue was recognized during the three and six months ended June 30, 2024 and 2023. Accounts Receivable. As of June 30, 2024 and December 31, 2023, the Company had an accounts receivable, net balance of $ 22,324 and $ 0 , respectively. As of June 30, 2024 and December 31, 2023, the Company had an allowance for doubtful accounts of $ 0 and $ 0 , respectively. Deferred revenue for the six months ended June 30, 2024 was as follows: Balance as of January 1, 2024 $ 935 Additions 7,700 Recognized as revenue ( 3,425 ) Balance as of June 30, 2024 $ 5,210 Other Assets: Other assets is comprised of the following: June 30, December 31, 2024 2023 Lease security deposit $ 625,000 $ 625,000 Spare machine parts 603,399 603,797 Total Other Assets $ 1,228,399 $ 1,228,797 Earnings per Share: Earnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. Basic EPS has been computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period. Income available to common stockholders has been computed by deducting dividends accumulated for the period on cumulative preferred stock (whether or not earned) and deemed dividends due to down round financings from net income. For the three and six months ended June 30, 2023, income available to common stockholders was adjusted for deemed dividends due to down round financings of $ 11,653,986 (See Note 10 in the Company's Annual Report on Form 10-K for the year ended December 31, 2023). Diluted earnings per share has been computed by dividing income available to common stockholders adjusted on an if-converted basis for the period by the weighted average number of common shares and potentially dilutive common share outstanding (which consist of warrants, options, restricted stock units and convertible securities using the if-converted or treasury stock method to the extent they are dilutive). Approximately 11.2 million and 0.28 million shares of dilutive shares were excluded from the three months period ended June 30, 2024 and 2023, respectively, EPS calculation as their impact is antidilutive. Approximately 7.6 million and 0.28 million shares of dilutive shares were excluded from the six months period ended June 30, 2024 and 2023, respectively, EPS calculation as their impact is antidilutive. Net loss attributable to common shareholders for the three and six months ended June 30, 2023 was as follows: Three months ended Six months ended June 30, 2023 June 30, 2023 Net Loss $ ( 3,913,472 ) $ ( 9,996,824 ) Down round deemed dividend ( 11,653,986 ) ( 11,653,986 ) Net Loss attributable to common shareholders ( 15,567,458 ) ( 21,650,810 ) Earnings Per Share (Basic and Diluted) ( 66.40 ) ( 105.08 ) Recently Issued Accounting Policies In November 2023, the FASB issued ASU 2023-07, Segment Reporting: Improvement to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 improves segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The amendments in ASU 2023-07 are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. Management is evaluating the impact of this ASU on the Company's financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes: Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 improves income tax disclosures by requiring public entities annually to (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 is effective for public entities for annual periods beginning after December 15, 2024. Entities are permitted to early adopt the standard for annual financial statements that have not yet been issued or made available for issuance. Management is evaluating the impact of this ASU on the Company's financial statements.

LIQUIDITY, CONTINUED OPERATIONS

LIQUIDITY, CONTINUED OPERATIONS, AND GOING CONCERN	6 Months Ended
	Jun. 30, 2024
Liquidity And Continued Operations [Abstract]
LIQUIDITY, CONTINUED OPERATIONS, AND GOING CONCERN	NOTE 4. LIQUIDITY, CONTINUED OPERATIONS, AND GOING CONCERN During the year ended December 31, 2023, the Company sold Series 1B preferred stock and completed a public offering to fund operations. Further discussion of these transactions can be found in Notes 13 and 14 in the Company's Annual Report on Form 10-K for the year ended December 31, 2023. The Company continues to enter into financing arrangements in 2024 to fund operations. The Company currently has limited production capabilities in its Thornton facility and continues to focus on restarting production at industrial scale while continuing its research and development activities to improve its PV products. The Company does not expect that sales revenue and cash flows will be sufficient to support operations and cash requirements until it has fully implemented this strategy. During the six months ended June 30, 2024, the Company used $ 4,846,465 in cash for operations. Current committed product revenues are not anticipated to result in a positive cash flow position for the next twelve months and although the Company has, as of June 30, 2024, working capital of $ 2,197,842 , Management does not believe cash liquidity is sufficient for the next twelve months and will require additional financing or committed purchase orders. The Company continues to look for ways to expand its production of PV films at industrial scale and to secure long-term contracts for the sale of such output. The Company also continues activities related to securing additional financing through strategic or financial investors, but there is no assurance the Company will be able to raise additional capital on acceptable terms or at all. If the Company's revenues do not increase rapidly, and/or additional financing is not obtained, the Company will be required to significantly curtail operations to reduce costs and/or sell assets. Such actions would likely have an adverse impact on the Company's future operations. As a result of the Company’s recurring losses from operations and the potential need for additional financing to fund its operating and capital requirements, there is uncertainty regarding the Company’s ability to maintain liquidity sufficient to operate its business effectively, which raises doubt as to the Company’s ability to continue as a going concern. Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. These condensed financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS In September 2021, the Company and TubeSolar AG ("TubeSolar"), a former significant stakeholder in the Company, entered into a Long-Term and Joint Development Agreement ("JDA") where the Company would provide PV foils for use in TubeSolar's solar modules for agricultural photovoltaic applications.The Company and TubeSolar also jointly established Ascent Solar Technologies Germany GmbH (“Ascent Germany”), in which TubeSolar holds of 30 % of the entity. Ascent Germany was established to operate a PV manufacturing facility in Germany that will produce and deliver PV Foils exclusively to TubeSolar. There were no Company contributions to Ascent Germany during the six months ended June 30, 2024 and 2023. In June, 2023, TubeSolar filed an application for insolvency proceedings with the insolvency court. Since then, there has been no activity under the JDA and minimal activity in Ascent Germany. Management continues to monitor this situation.

ASSET ACQUISITION

ASSET ACQUISITION	6 Months Ended
	Jun. 30, 2024
Asset Acquisition [Abstract]
ASSET ACQUISITION	NOTE 6. SWITZERLAND ASSETS On April 17, 2023 , the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with Flisom AG (“Seller”), pursuant to which, among other things, the Company purchased certain assets relating to thin-film photovoltaic manufacture and production from Seller (collectively, the “Assets”). The purchase price paid by the Company was $ 4,083,926 (including $ 1,283,926 of transaction costs). The Company also entered into a sublease agreement allowing the Company to use the manufacturing facility where the Assets are located. During the year ended December 31, 2023, Management concluded that these assets were impaired and recognized an impairment loss of $ 3,283,715 . The remaining carrying value of the Assets, as of December 31, 2023, was $ 786,000 . On April 1, 2024, the Company entered into an agreement with the manufacturing facility landlord (“Landlord”) and sold all but one piece of equipment from the Assets to the Landlord for 1 CHF and forgiveness of $ 221,519 in payables and any potential future claims the manufacturing facility Landlord may have. The carrying value of the Assets sold was $ 746,000 . At March 31, 2024, the Company designated the Assets as assets held for sale as all of the following criteria have been met: (i) a formal commitment to a plan to sell a property has been made and exercised; (ii) the property is available for sale in its present condition; (iii) actions required to complete the sale of the property have been initiated; (iv) sale of the property is probable and we expect the sale will occur within one year; and (v) the property is being actively marketed for sale at a price that is reasonable given its current market value. Assets held for sale were recorded in Property, Plant and Equipment, net in the unaudited condensed balance sheets. Upon designation as an asset held for sale, the Company recorded the carrying value of the property at the lower of its carrying value or its estimated fair value, less estimated costs to sell, and depreciation of the property ceases. As the estimated fair value of $ 221,519 , the price the Company sold the Assets for is less than their carrying value, the Company recorded an impairment loss of $ 524,481 . Upon completion of the sale, on April 1, 2024, the Company wrote off the remaining carrying value of the Assets and the payables to the Landlord.

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	NOTE 7. PROPERTY, PLANT AND EQUIPMENT The following table summarizes property, plant and equipment as of June 30, 2024 and December 31, 2023: As of As of 2024 2023 Furniture, fixtures, computer hardware and $ 468,588 $ 468,588 Manufacturing machinery and equipment 19,162,828 20,661,222 Leasehold improvements 15,994 15,995 Manufacturing machinery and equipment, 32,087 32,087 Depreciable property, plant and equipment 19,679,497 21,177,892 Less: Accumulated depreciation and amortization ( 19,412,704 ) ( 20,131,008 ) Net property, plant and equipment $ 266,793 $ 1,046,884 Depreciation expense for the three months ended June 30, 2024 and 2023 was $ 17,045 and $ 19,650 , respectively. Depreciation expense for the six months ended June 30, 2024 and 2023 was $ 34,091 and $ 40,639 , respectively. Depreciation expense is recorded under “Depreciation and amortization expense” in the unaudited Condensed Statements of Operations.

OPERATING LEASE

OPERATING LEASE	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
OPERATING LEASE	NOTE 8. OPERATING LEASE The Company’s lease is primarily comprised of manufacturing and office space. This lease is classified and accounted for as an operating lease. The building lease term is for 88 months commencing on September 21, 2020 at a rent of $ 50,000 per month including taxes, insurance and common area maintenance until December 31, 2020. Beginning January 1, 2021, the rent adjusted to $ 80,000 per month on a triple net basis and shall increase at an annual rate of 3 % per annum until December 31, 2027. Effective September 1, 2023, the lease was amended to reduce the rentable square feet from approximately 100,000 to approximately 75,000 square feet and the rent and tenant share of expenses were decreased in proportion to the reduction in the rentable square feet. As of June 30, 2024 and December 31, 2023, assets and liabilities related to the Company’s leases were as follows: As of As of 2024 2023 Operating lease right-of-use assets, net $ 2,129,854 $ 2,364,672 Current portion of operating lease liability 533,503 491,440 Non-current portion of operating lease liability 1,762,575 2,043,025 During the three months ended June 30, 2024 and 2023, the Company recorded operating lease expense included in selling, general and administrative expenses of $ 190,497 and $ 271,542 , respectively. During the six months ended June 30, 2024 and 2023, the Company recorded operating lease expense included in selling, general and administrative expenses of $ 380,995 and $ 533,910 , respectively. Future maturities of the operating lease liability are as follows: Remainder of 2024 $ 384,565 2025 792,203 2026 815,969 2027 840,449 Total lease payments 2,833,186 Less amounts representing interest ( 537,108 ) Present value of lease liability $ 2,296,078 The remaining weighted average lease term and discount rate of the operating leases is 42 months and 7.0 % , respectively.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
INVENTORIES	NOTE 9. INVENTORIES Inventories, net of reserves, consisted of the following at June 30, 2024 and December 31, 2023: As of As of 2024 2023 Raw materials $ 460,165 $ 445,721 Work in process 691 1,775 Finished goods - - Total $ 460,856 $ 447,496

BRIDGE LOAN

BRIDGE LOAN	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
BRIDGE LOAN	NOTE 10. BRIDGE LOAN Principal New loans Principal Payments Principal Discount Bridge Loan, net of discount Bridge Loans $ — $ 1,240,800 $ ( 560,756 ) $ 680,044 $ ( 42,293 ) $ 637,751 On February 27, 2024, the Company entered into a loan agreement ("Loan 1") with a lender ("Lender") for an aggregate principal amount of $ 375,000 . The Company paid origination fees of $ 25,000 for net proceeds of $ 350,000 . The discount is recorded as interest expense ratably over the term of the loan. Under Loan 1, the Company will make weekly payments of $ 19,420 for 28 weeks for a total repayment of $ 543,750 . The Company also had an early repayment option where the Company would repay an aggregate of $ 478,125 if repaid by April 15, 2024. On April 17, 2024, the Company entered into a new loan agreement ("Loan 2") with the Lender. Under Loan 2, the Company borrowed an aggregate principal amount of $ 685,000 , incurred origination fees of $ 34,250 , and repaid the outstanding balance of Loan 1 of $ 428,310 for net proceeds of $ 222,440 . Under Loan 2, the Company will make weekly payments of $ 31,000 for 32 weeks for a total repayment of $ 993,250 . This loan is secured by a lien on the Company's assets. As of June 30, 2024, principal and interest payable on Loan 2 was $ 524,420 and $ 5,452 , respectively. The Company also recognized $ 360,039 in interest expense during the six months ended June 30, 2024. On April 1 and 2, 2024, the Company closed two loan agreements with a different lender ("Lender 2") for an aggregate principal amount of $ 180,800 . These loans have an original issuance discount of $ 20,800 for net proceeds of $ 160,000 . The Company will repay a total of $ 202,496 under these loans. The loans mature on January 1, 2025 and are payable in monthly installments as defined in the loan agreements. Upon a default event, outstanding principal and interest payable is convertible into Company stock at a 25 % discount; however, the conversion price cannot be below $ 0.25 . At June 30, 2024, principal and interest payable on these loans was $ 155,624 and $ 5,980 , respectively. The Company also recognized $ 17,962 in interest expense during the six months ended June 30, 2024. The carrying amount of these bridge loans approximate fair value due to its short maturity and because the Company's current borrowing rate does not materially differ from market rates for similar bank borrowings and is considered to be Level 2 input on the fair value hierarchy .

OTHER PAYABLE

OTHER PAYABLE	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
OTHER PAYABLE	NOTE 11. OTHER PAYABLE On June 30, 2017, the Company entered into an agreement with a vendor (“Vendor”) to convert the balance of their account into a note payable in the amount of $ 250,000 . The note bears interest of 5 % per annum and matured on February 28, 2018. As of June 30, 2024, the Company had not made any payments on this note, the accrued interest was $ 87,568 , and the note is due upon demand. This note is recorded as Other payable in the unaudited Condensed Balance Sheets.

CONVERTIBLE NOTES

CONVERTIBLE NOTES	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
CONVERTIBLE NOTES	NOTE 12. CONVERTIBLE NOTES The following table provides a summary of the activity of the Company's secured, convertible, promissory notes: Principal Notes converted Notes paid Net Principal L1 Capital Global Opportunities Master Fund, Ltd $ 406,667 $ ( 400,000 ) $ ( 6,667 ) $ — During the six months ended June 30, 2024 , $ 400,000 of principal was converted for 618,384 shares of common stock. The note matured on June 19, 2024 and the Company paid the remaining principal and interest payable. During the three months ended June 30, 2024 and 2023 , the Company had interest expense of $ 463 and $ 746,578 , respectively, of which, $ 397 and $ 640,438 , respectively was due to accretion of discount on the note. During the six months ended June 30, 2024 and 2023 , the Company had interest expense of $ 463,397 and $ 1,799,506 , respectively, of which, $ 19,260 and $ 1,542,097 , respectively was due to accretion of discount on the note. Conversions Payable represents the economic difference between the applicable conversion price of the notes payable and floor price of $ 0.65 . This amount is payable either in shares valued as the VWAP on the conversion day or in cash. If the VWAP on the conversion day is less than the floor price, then the economic different between the conversion day VWAP and the floor price becomes payable in cash and is recorded as Cash payable on the unaudited Condensed Balance Sheet. During the three months ended March 31, 2024, $ 1,279,782 of conversions payable was converted into 1,793,404 shares of common stock and $ 199,997 of Cash payable. The Cash payable was paid in April 2024 with the close of the Company's public offering (see Note 15).

SERIES A PREFERRED STOCK

SERIES A PREFERRED STOCK	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Series A Preferred Stock	NOTE 13. SERIES A PREFERRED STOCK As of January 1, 2024, there were 48,100 shares of Series A Preferred Stock outstanding. Holders of Series A Preferred Stock are entitled to cumulative dividends at a rate of 8 % per annum when and if declared by the Board of Directors at its sole discretion. The dividends may be paid in cash or in the form of common stock (valued at 10 % below market price, but not to exceed the lowest closing price during the applicable measurement period), at the discretion of the Board of Directors. The dividend rate on the Series A Preferred Stock is indexed to the Company's stock price and subject to adjustment. The Series A Preferred Stock may be converted into shares of common stock at the option of the Company if the closing price of the common stock exceeds $ 232 million, adjusted for reverse stock splits, for twenty consecutive trading days, or by the holder at any time. The Company has the right to redeem the Series A Preferred Stock at a price of $ 8.00 per share, plus any accrued and unpaid dividends, plus the make-whole amount (if applicable). At June 30, 2024 , the preferred shares were not eligible for conversion to common shares at the option of the Company. The holder of the preferred shares may convert to common shares at any time. After making adjustment for the Company’s prior reverse stock splits, all 48,100 outstanding Series A preferred shares are convertible into less than one common share. Upon any conversion (whether at the option of the Company or the holder), the holder is entitled to receive any accrued but unpaid dividends. Except as otherwise required by law (or with respect to approval of certain actions), the Series A Preferred Stock shall have no voting rights. Upon any liquidation, dissolution or winding up of the Company, after payment or provision for payment of debts and other liabilities of the Company, the holders of Series A Preferred Stock shall be entitled to receive, pari passu with any distribution to the holders of common stock of the Company, an amount equal to $8.00 per share of Series A Preferred Stock plus any accrued and unpaid dividends. As of June 30, 2024 , there were 48,100 shares of Series A Preferred Stock outstanding and accrued and unpaid dividends of $ 538,586 .

SERIES Z PREFERRED STOCK

SERIES Z PREFERRED STOCK	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
SERIES Z PREFERRED STOCK	NOTE 14. SERIES Z PREFERRED STOCK On June 20, 2024, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Paul Warley, the Company’s Chief Executive Officer (the “Purchaser”) pursuant to which it issued and sold one (1) share (the “Share”) of the Company’s newly designated Series Z Preferred Stock, par value $ 0.0001 per share (the “Series Z Preferred Stock”), to such Purchaser for an aggregate purchase price of $ 1,000 . The Share of Series Z Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Share of Series Z Preferred Stock has no rights with respect to any distribution of assets of the Company, including upon a liquidation, bankruptcy, reorganization, merger, acquisition, sale, dissolution or winding up of the Company, whether voluntarily or involuntarily. The holder of the Share of Series Z Preferred Stock will not be entitled to receive dividends of any kind. The outstanding share of Series Z Preferred Stock shall be redeemed in whole, but not in part, at any time (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the Certificate of Incorporation implementing a reverse stock split. Upon such redemption, the holder of the Series Z Preferred Stock will receive consideration of $ 1,000 in cash. The Share of Series Z Preferred Stock will have 180,000,000 votes and will vote together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to any proposal to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. The Share of Series Z Preferred Stock will be voted, without action by the holder, on any such reverse stock split proposal in the same proportion as shares of common stock are voted on such proposal (excluding any common shares that are not voted). The Series Z Preferred Stock otherwise has no voting rights, except as may otherwise be required by the General Corporation Law of the State of Delaware. The Series Z Preferred Stock is recorded as Accrued Expenses in the unaudited Condensed Balance Sheets.

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT)	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 15. STOCKHOLDERS’ EQUITY (DEFICIT) Common Stock At June 30, 2024 , the Company had 500 million shares of common stock, $ 0.0001 par value, authorized for issuance. Each share of common stock has the right to one vote. As of June 30, 2024, the Company had 98,825,076 shares of common stock outstanding. The Company has not declared or paid any dividends related to the common stock during the three or six months ended June 30, 2024 and 2023. During the six months ended June 30, 2024 , $ 400,000 million of convertible debt principal was converted into 618,384 shares of common stock $ 1,279,782 of conversions payable was converted into 1,793,404 shares of common stock. 350,000 shares of common stock was also issued to settle liabilities. As part of the December 19, 2022 Securities Purchase Contract (the “Purchase Contract”) with two institutional investors (the “Investors”), the Company issued to the Investors certain common stock warrants (the “Warrants”). The Warrants have certain “full ratchet” anti-dilution adjustments that are triggered when the Company issues securities with a purchase or conversion, exercise or exchange price that is less than the exercise price of the Warrants then in effect at any time. Under the full ratchet anti-dilution adjustments, if the Company issues new securities at a price lower than the then applicable exercise price, (i) the exercise price is reduced to the lower new issue price and (ii) the number of warrant shares is proportionately increased. The Warrants have been previously adjusted following past issuances of Company securities. As of March 31, 2024, there were 5,596,232 Warrants exercisable at an exercise price of $ 1.765 . On March 6, 2024 and March 7, 2024 , the Company entered into Warrant Repurchase Agreements (the “Repurchase Agreements”), with each of the Investors. Pursuant to the Repurchase Agreements, if the Company closes a new capital raising transaction with gross proceeds in excess of $ 5 million (“Qualified Financing”), the Company will repurchase the Warrants from the Investors for an aggregate purchase price of $ 3.6 million. Following the delivery of the purchase price to the Investors, the Investors will relinquish all rights, title and interest in the Warrants and assign the same to the Company, and the Warrants will be cancelled. On April 12, 2024, the Company entered into Amended and Restated Warrant Repurchase Agreements (the “Amendments”) with each of the Investors. Pursuant to the Amendments, on April 12, 2024, the Company and the Investors agreed to the following: • First Repurchase. On April 12, 2024, the Investors agree to convey, assign and transfer 50 % of the Warrants to the Company in exchange for the payment by the Company for an aggregate purchase price of $ 1.8 million. • Second Repurchase. On or before April 18, 2024, the Investors agree to convey, assign and transfer all remaining Warrants to the Company for an aggregate purchase price of $ 1.8 million. To extend the repurchase deadline, on April 12, 2024 the Company agreed to issue the Investors approximately 7.1 million warrants in aggregate at an exercise price of $ 0.14 per warrant. These warrants will be exercisable at any time, and from time to time, in whole or in part, commencing six months from the closing of the offering and expiring five and a half ( 5.5 ) years from the date of issue, and will be exercisable for cash only unless an effective registration statement is not available at the time of exercise, in which case the warrants could be exercised on a cashless basis. The Company recorded an expense of $ 743,459 as Warrant settlement expense on the unaudited Condensed Statement of Operations and Comprehensive Income. The expense represents the estimated fair value of the warrants at the issuance date and was determined using the Black Scholes model using the following inputs: Inputs Expected stock price volatility 154.5 % Dividend yield 0 % Risk-free interest rate 4.75 % Expected life of the warrants (in years) 2.75 On April 9, 2024 the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with Dawson James Securities Inc. (“Dawson James”) pursuant to which the Company engaged Dawson James as the placement agent for a registered public offering by the Company (the “Offering”), of up to $ 6 million of shares of common stock or, in lieu of common stock, one prefunded warrant to purchase a share of common stock on a best efforts basis. The Company agreed to pay Dawson James a placement agent fee in cash equal to 8.00 % of the gross proceeds from the sale of the shares of common stock; provided, however, that the placement agent fee shall equal 4 % for investors that the Company directs to the Offering. The Company also agreed to reimburse Dawson James for all reasonable travel and other out-of-pocket expenses, including the reasonable fees of legal counsel, not to exceed $ 155,000 . On April 18, 2024, the Company, completed closings under the Offering of common stock. Aggregate gross proceeds from all closings under the offering total $ 5.09 million before deducting offering expenses. In the completed closings, the Company issued an aggregate of (i) 15,179,460 common shares and (ii) 21,162,277 Pre-Funded Warrants. The Pre-Funded Warrants are immediately exercisable at a price of $ 0.0001 per share of common stock and only expire when such Pre-Funded warrants are fully exercised. As of June 30, 2024, all 21,162,277 of the Pre-Funded Warrants were exercised into common stock. The net proceeds from the closings of the Offering were utilized to retire approximately $ 200,000 of cash payable and $ 3.6 million to repurchase and cancel a total of 5,596,232 outstanding common warrants with an exercise price of $ 1.765 per share that were both issued with our secured notes issued in December 2022. The repurchase of these warrants eliminated a substantial potential future issuance of common stock at a substantially reduced price. These warrants would have been adjusted in accordance with their terms to provide for the purchase of 70,554,495 shares of the Company’s common stock at an exercise price of $ 0.14 if they had not been repurchased by the Company. On May 16, 2024, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (“Wainwright”), to sell shares of its common stock, par value $ 0.0001 per share (the “Shares”), having an aggregate sales price of up to $ 4,219,000 , from time to time, through an “at the market offering” program under which Wainwright will act as sales agent. The sales, if any, of the Shares made under the ATM Agreement will be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), including sales made directly on or through the Nasdaq Capital Market or on any other existing trading market for the Company’s common stock. The Company will pay Wainwright a commission rate equal to 3.0 % of the aggregate gross proceeds from each sale of Common Stock and will also reimburse Wainwright for certain specified expenses in connection with entering into the ATM Agreement, including certain fees and out-of-pocket expenses of its legal counsel. On May 23, 2024, the Company increased the amount available for sale under the ATM Agreement, up to an additional aggregate offering price of $ 4,344,000 and on May 30, 2024, the Company again increased the amount available for sale under the ATM Agreement by an additional aggregate offering price of $ 3,981,000 . As of June 30, 2024, the Company sold 55,342,643 shares of common stock at an average price of $ 0.162 per share, resulting in aggregate gross proceeds of approximately $ 8.96 million. The Company anticipates that the at-the-market offering will continue throughout the next reporting period. Preferred Stock At June 30, 2024 , the Company had 25 million shares of preferred stock, $ 0.0001 par value, authorized for issuance. Preferred stock may be issued in classes or series. Designations, powers, preferences, rights, qualifications, limitations and restrictions are determined by the Company’s Board of Directors. The following table summarizes the designations, shares authorized, and shares outstanding for the Company’s Preferred Stock: Preferred Stock Series Designation Shares Shares Series A 750,000 48,100 Series 1A 5,000 — Series B-1 2,000 — Series B-2 1,000 — Series 1B 900 — Series C 1,000 — Series D 3,000 — Series D-1 2,500 — Series E 2,800 — Series F 7,000 — Series G 2,000 — Series H 2,500 — Series I 1,000 — Series J 1,350 — Series J-1 1,000 — Series K 20,000 — Series Z 1 1 Warrants As of June 30, 2024 , there are 11,877,142 outstanding warrants with exercise prices between $ 0.14 and $ 1,060 per share. Series A Preferred Stock Refer to Note 13 for information on Series A Preferred Stock. Series Z Preferred Stock Refer to Note 14 for information on Series Z Preferred Stock. Series 1A, B-1, B-2, C, D, D-1, E, F, G, H, I, J, J-1, and K Preferred Stock There were no transactions involving the Series 1A, B-1, B-2, C, D, D-1, E, F, G, H, I, J, J-1, or K during the three and six months ended June 30, 2024 .

SHARE-BASED COMPENSATION

SHARE-BASED COMPENSATION	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION	NOTE 16. SHARE-BASED COMPENSATION In January 2024, the Company granted 459,000 shares of restricted stock units to employees and directors. One third of these shares vested on March 31, 2024 . The remaining unvested shares will vest prorata on January 1, 2025 and January 1, 2026 . The Company also granted members of our advisory board an aggregate of 20,000 shares of restricted stock units. The advisory shares originally vested prorata on January 1, 2025 and January 1, 2026 ; however, were amended to vest prorata on June 30, 2024 and January 1, 2025 . The Company had a total of 316,964 unvested units as of June 30, 2024 that are expected to vest in the future. Total unrecognized share-based compensation expense from the remaining unvested restricted stock as of June 30, 2024 was approximately $ 1,220,860 and is expected to be recognized over 1.75 years. The following table summarizes non-vested restricted stock and the related activity as of June 30, 2024: Shares Weighted Average Grant Date Fair Value Non-vested at January 1, 2024 1,867 $ 596.00 Granted 481,000 0.76 Vested ( 163,903 ) 1.61 Forfeited ( 2,000 ) 0.77 Non-vested at June 30, 2024 316,964 $ 5.06 The fair values of the respective vesting dates of RSUs were approximately $ 61,563 and $ 233,731 for the six months ended June 30, 2024 and 2023, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 17. COMMITMENTS AND CONTINGENCIES On August 15, 2023, H.C. Wainwright & Co., LLC (“Wainwright”) filed an action against the Company in the New York State Supreme Court in New York County. The complaint alleges a breach by the Company of an investment banking engagement letter entered into in October 2021. The Wainwright engagement letter expired in April 2022 without any financing transaction having been completed. The complaint claims that Wainright is entitled, under a “tail provision”, to an 8 % fee and 7 % warrant coverage on the Company’s $ 15 million secured convertible note financing. The complaint seeks damages of $ 1.2 million, 2,169.5 common stock warrants with a per share exercise price of $ 605 , and attorney fees. On May 15, 2024, the Company and Wainwright reached a settlement agreement. The settlement did not have a material impact on our financial statements. The Company is subject to various legal proceedings, both asserted and unasserted, that arise in the ordinary course of business. The Company cannot predict the ultimate outcome of such legal proceedings or in certain instances provide reasonable ranges of potential losses. However, as of the date of this report, the Company believes that none of these claims will have a material adverse effect on its financial position or results of operations. In the event of unexpected subsequent developments and given the inherent unpredictability of these legal proceedings, there can be no assurance that the Company’s assessment of any claim will reflect the ultimate outcome, and an adverse outcome in certain matters could, from time to time, have a material adverse effect on the Company’s financial position or results of operations in particular quarterly or annual periods.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 18. SUBSEQUENT EVENTS Subsequent to June 30, 2024, the Company sold 3,519,100 shares of common stock under the ATM Agreement at an average price of $ 0.113 per share, resulting in aggregate gross proceeds of approximately $ 399,300 .

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition: Product revenue. The Company recognizes revenue for the sale of PV modules and other equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. For module and other equipment sales contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices, or estimates of such prices, and recognizes the related revenue as control of each individual product is transferred to the customer. During the three months ended June 30, 2024 and 2023, the Company recognized product revenue of $ 27,743 and $ 86,385 , respectively. During the six months ended June 30, 2024 and 2023, the Company recognized product revenue of $ 33,343 and $ 185,610 , respectively. Milestone and engineering revenue. Each milestone and engineering arrangement is a separate performance obligation. The transaction price is estimated using the most likely amount method and revenue is recognized as the performance obligation is satisfied through achieving manufacturing, cost, or engineering targets. During the three months ended June 30, 2024 and 2023, the Company recognized total milestone and engineering revenue of $ 0 and $ 14,916 , respectively. During the six months ended June 30, 2024 and 2023, the Company recognized total milestone and engineering revenue of $ 0 and $ 39,916 , respectively. Government contracts revenue. Revenue from government research and development contracts is generated under terms that are cost plus fee or firm fixed price. The Company generally recognizes this revenue over time using cost-based input methods, which recognizes revenue and gross profit as work is performed based on the relationship between actual costs incurred compared to the total estimated costs of the contract. In applying cost-based input methods of revenue recognition, the Company uses the actual costs incurred relative to the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize. Cost based input methods of revenue recognition are considered a faithful depiction of the Company’s efforts to satisfy long-term government research and development contracts and therefore reflect the performance obligations under such contracts. Costs incurred that do not contribute to satisfying the Company’s performance obligations are excluded from the input methods of revenue recognition as the amounts are not reflective of transferring control under the contract. Costs incurred towards contract completion may include direct costs plus allowable indirect costs and an allocable portion of the fixed fee. If actual and estimated costs to complete a contract indicate a loss, provision is made currently for the loss anticipated on the contract. No government contract revenue was recognized during the three and six months ended June 30, 2024 and 2023. Accounts Receivable. As of June 30, 2024 and December 31, 2023, the Company had an accounts receivable, net balance of $ 22,324 and $ 0 , respectively. As of June 30, 2024 and December 31, 2023, the Company had an allowance for doubtful accounts of $ 0 and $ 0 , respectively. Deferred revenue for the six months ended June 30, 2024 was as follows: Balance as of January 1, 2024 $ 935 Additions 7,700 Recognized as revenue ( 3,425 ) Balance as of June 30, 2024 $ 5,210 Other Assets: Other assets is comprised of the following: June 30, December 31, 2024 2023 Lease security deposit $ 625,000 $ 625,000 Spare machine parts 603,399 603,797 Total Other Assets $ 1,228,399 $ 1,228,797
Earnings Per Share	Earnings per Share: Earnings per share (“EPS”) are the amount of earnings attributable to each share of common stock. Basic EPS has been computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period. Income available to common stockholders has been computed by deducting dividends accumulated for the period on cumulative preferred stock (whether or not earned) and deemed dividends due to down round financings from net income. For the three and six months ended June 30, 2023, income available to common stockholders was adjusted for deemed dividends due to down round financings of $ 11,653,986 (See Note 10 in the Company's Annual Report on Form 10-K for the year ended December 31, 2023). Diluted earnings per share has been computed by dividing income available to common stockholders adjusted on an if-converted basis for the period by the weighted average number of common shares and potentially dilutive common share outstanding (which consist of warrants, options, restricted stock units and convertible securities using the if-converted or treasury stock method to the extent they are dilutive). Approximately 11.2 million and 0.28 million shares of dilutive shares were excluded from the three months period ended June 30, 2024 and 2023, respectively, EPS calculation as their impact is antidilutive. Approximately 7.6 million and 0.28 million shares of dilutive shares were excluded from the six months period ended June 30, 2024 and 2023, respectively, EPS calculation as their impact is antidilutive. Net loss attributable to common shareholders for the three and six months ended June 30, 2023 was as follows: Three months ended Six months ended June 30, 2023 June 30, 2023 Net Loss $ ( 3,913,472 ) $ ( 9,996,824 ) Down round deemed dividend ( 11,653,986 ) ( 11,653,986 ) Net Loss attributable to common shareholders ( 15,567,458 ) ( 21,650,810 ) Earnings Per Share (Basic and Diluted) ( 66.40 ) ( 105.08 )
Recently Issued Accounting Policies	Recently Issued Accounting Policies In November 2023, the FASB issued ASU 2023-07, Segment Reporting: Improvement to Reportable Segment Disclosures ("ASU 2023-07"). ASU 2023-07 improves segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. In addition, the amendments enhance interim disclosure requirements, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, provide new segment disclosure requirements for entities with a single reportable segment, and contain other disclosure requirements. The amendments in ASU 2023-07 are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. Management is evaluating the impact of this ASU on the Company's financial statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes: Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 improves income tax disclosures by requiring public entities annually to (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 is effective for public entities for annual periods beginning after December 15, 2024. Entities are permitted to early adopt the standard for annual financial statements that have not yet been issued or made available for issuance. Management is evaluating the impact of this ASU on the Company's financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Deferred Revenue	Deferred revenue for the six months ended June 30, 2024 was as follows: Balance as of January 1, 2024 $ 935 Additions 7,700 Recognized as revenue ( 3,425 ) Balance as of June 30, 2024 $ 5,210
Other Assets	Other Assets: Other assets is comprised of the following: June 30, December 31, 2024 2023 Lease security deposit $ 625,000 $ 625,000 Spare machine parts 603,399 603,797 Total Other Assets $ 1,228,399 $ 1,228,797
Net Loss Attributable to Common Shareholders	Net loss attributable to common shareholders for the three and six months ended June 30, 2023 was as follows: Three months ended Six months ended June 30, 2023 June 30, 2023 Net Loss $ ( 3,913,472 ) $ ( 9,996,824 ) Down round deemed dividend ( 11,653,986 ) ( 11,653,986 ) Net Loss attributable to common shareholders ( 15,567,458 ) ( 21,650,810 ) Earnings Per Share (Basic and Diluted) ( 66.40 ) ( 105.08 )

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	The following table summarizes property, plant and equipment as of June 30, 2024 and December 31, 2023: As of As of 2024 2023 Furniture, fixtures, computer hardware and $ 468,588 $ 468,588 Manufacturing machinery and equipment 19,162,828 20,661,222 Leasehold improvements 15,994 15,995 Manufacturing machinery and equipment, 32,087 32,087 Depreciable property, plant and equipment 19,679,497 21,177,892 Less: Accumulated depreciation and amortization ( 19,412,704 ) ( 20,131,008 ) Net property, plant and equipment $ 266,793 $ 1,046,884

OPERATING LEASE (Tables)

OPERATING LEASE (Tables)	6 Months Ended
	Jun. 30, 2024
Leases [Abstract]
Schedule of Assets and Liabilities Related to Company's Leases	As of June 30, 2024 and December 31, 2023, assets and liabilities related to the Company’s leases were as follows: As of As of 2024 2023 Operating lease right-of-use assets, net $ 2,129,854 $ 2,364,672 Current portion of operating lease liability 533,503 491,440 Non-current portion of operating lease liability 1,762,575 2,043,025
Schedule Future Maturities of Operating Lease Liability	Future maturities of the operating lease liability are as follows: Remainder of 2024 $ 384,565 2025 792,203 2026 815,969 2027 840,449 Total lease payments 2,833,186 Less amounts representing interest ( 537,108 ) Present value of lease liability $ 2,296,078

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory, Net of Reserves	Inventories, net of reserves, consisted of the following at June 30, 2024 and December 31, 2023: As of As of 2024 2023 Raw materials $ 460,165 $ 445,721 Work in process 691 1,775 Finished goods - - Total $ 460,856 $ 447,496

BRIDGE LOAN (Tables)

BRIDGE LOAN (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Summary of Bridge Loan	Principal New loans Principal Payments Principal Discount Bridge Loan, net of discount Bridge Loans $ — $ 1,240,800 $ ( 560,756 ) $ 680,044 $ ( 42,293 ) $ 637,751

CONVERTIBLE NOTES (Tables)

CONVERTIBLE NOTES (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Debt	The following table provides a summary of the activity of the Company's secured, convertible, promissory notes: Principal Notes converted Notes paid Net Principal L1 Capital Global Opportunities Master Fund, Ltd $ 406,667 $ ( 400,000 ) $ ( 6,667 ) $ —

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Schedule of Fair Value of Warrants	The expense represents the estimated fair value of the warrants at the issuance date and was determined using the Black Scholes model using the following inputs: Inputs Expected stock price volatility 154.5 % Dividend yield 0 % Risk-free interest rate 4.75 % Expected life of the warrants (in years) 2.75
Schedule of Stock by Class	The following table summarizes the designations, shares authorized, and shares outstanding for the Company’s Preferred Stock: Preferred Stock Series Designation Shares Shares Series A 750,000 48,100 Series 1A 5,000 — Series B-1 2,000 — Series B-2 1,000 — Series 1B 900 — Series C 1,000 — Series D 3,000 — Series D-1 2,500 — Series E 2,800 — Series F 7,000 — Series G 2,000 — Series H 2,500 — Series I 1,000 — Series J 1,350 — Series J-1 1,000 — Series K 20,000 — Series Z 1 1

SHARE-BASED COMPENSATION (Table

SHARE-BASED COMPENSATION (Tables)	6 Months Ended
	Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Non-vested Restricted Stock and Related Activity	Shares Weighted Average Grant Date Fair Value Non-vested at January 1, 2024 1,867 $ 596.00 Granted 481,000 0.76 Vested ( 163,903 ) 1.61 Forfeited ( 2,000 ) 0.77 Non-vested at June 30, 2024 316,964 $ 5.06

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($) shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Finite Lived Intangible Assets [Line Items]
Revenues	$ 27,743	$ 101,301	$ 33,343	$ 225,526
Revenue recognized			3,425
Accounts receivable, net balance	22,324		22,324		$ 0
Allowance for doubtful accounts	$ 0		$ 0		$ 0
Shares omitted from loss per share, anti-dilutive	11,200	280	7,600	280
Income available to common stockholders adjusted for deemed dividends from down round financings		$ 11,653,986		$ 11,653,986
Products
Finite Lived Intangible Assets [Line Items]
Revenues	$ 27,743	86,385	$ 33,343	185,610
Milestone and Engineering Arrangement
Finite Lived Intangible Assets [Line Items]
Revenue recognized	0	14,916	0	39,916
Government Research and Development
Finite Lived Intangible Assets [Line Items]
Revenues	$ 0	$ 0	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Deferred Revenue (Details)	6 Months Ended
	Jun. 30, 2024 USD ($)
Accounting Policies [Abstract]
Beginning Balance	$ 935
Additions	7,700
Recognized as revenue	(3,425)
Ending Balance	$ 5,210

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Other Assets (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Lease security deposit	$ 625,000	$ 625,000
Spare machine parts	603,399	603,797
Total Other Assets	$ 1,228,399	$ 1,228,797

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Net Loss Attributable to Common Shareholders (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net Income (Loss)	$ (3,445,827)	$ (2,537,742)	$ (3,913,472)	$ (6,083,352)	$ (5,983,569)	$ (9,996,824)
Down round deemed dividend			(11,653,986)			(11,653,986)
Net Loss attributable to common shareholders			$ (15,567,458)			$ (21,650,810)
Earnings Per Share (Basic)	$ (0.07)		$ (66.4)		$ (0.21)	$ (105.08)
Earnings Per Share (Diluted)	$ (0.07)		$ (66.4)		$ (0.21)	$ (105.08)

LIQUIDITY, CONTINUED OPERATIO_2

LIQUIDITY, CONTINUED OPERATIONS, AND GOING CONCERN - Additional Information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Liquidity And Continued Operations [Abstract]
Net cash used in operating activities	$ 4,846,465	$ 6,577,826
Working capital	$ 2,197,842

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Revenue recognized	$ 5,210	$ 935
TubeSolar AG | JV
Related Party Transaction [Line Items]
Minority stake percentage	30%

ASSET ACQUISITION - Additional

ASSET ACQUISITION - Additional Information (Details) - USD ($)			6 Months Ended	12 Months Ended
	Apr. 01, 2024	Apr. 17, 2023	Jun. 30, 2024	Dec. 31, 2023
Asset Acquisition [Line Items]
Impairment loss			$ 524,481
Carrying value of assets			266,793	$ 1,046,884
Estimated fair value			$ 221,519
Flisom AG | Photovoltaic Thin Film Solar Cells | Asset Purchase Agreement
Asset Acquisition [Line Items]
Date of asset acquisition agreement		Apr. 17, 2023
Purchase price paid		$ 4,083,926
Purchase price, including transaction costs		$ 1,283,926
Impairment loss				3,283,715
Carrying value of assets				$ 786,000
Manufacturing Facility Landlord
Asset Acquisition [Line Items]
Carrying value of assets sold	$ 746,000
Asset selling terms	On April 1, 2024, the Company entered into an agreement with the manufacturing facility landlord (“Landlord”) and sold all but one piece of equipment from the Assets to the Landlord for 1 CHF and forgiveness of $221,519 in payables and any potential future claims the manufacturing facility Landlord may have.
Forgiveness of payables	$ 221,519

PROPERTY, PLANT AND EQUIPMENT -

PROPERTY, PLANT AND EQUIPMENT - Schedule of Property, Plant and Equipment (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Depreciable property, plant and equipment	$ 19,679,497	$ 21,177,892
Less: Accumulated depreciation and amortization	(19,412,704)	(20,131,008)
Property, Plant and Equipment, net	266,793	1,046,884
Furniture, fixtures, computer hardware and computer software
Property Plant And Equipment [Line Items]
Depreciable property, plant and equipment	468,588	468,588
Manufacturing machinery and equipment
Property Plant And Equipment [Line Items]
Depreciable property, plant and equipment	19,162,828	20,661,222
Leasehold improvements
Property Plant And Equipment [Line Items]
Depreciable property, plant and equipment	15,994	15,995
Manufacturing machinery and equipment, in progress
Property Plant And Equipment [Line Items]
Depreciable property, plant and equipment	$ 32,087	$ 32,087

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 17,045	$ 19,650	$ 34,091	$ 40,639

OPERATING LEASE - Additional In

OPERATING LEASE - Additional Information (Details)			3 Months Ended		6 Months Ended
	Jan. 01, 2021 USD ($)	Sep. 21, 2020 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Sep. 01, 2023 ft²	Aug. 31, 2023 ft²
Lessee, Lease, Description [Line Items]
Lease term			88 months		88 months
Lease commencement date		Sep. 21, 2020
Rent per month | $	$ 80,000	$ 50,000
Percentage of rent increase in annual rate					3%
Net rentable area | ft²								100,000
Lease terms description					This lease is classified and accounted for as an operating lease. The building lease term is for 88 months commencing on September 21, 2020 at a rent of $50,000 per month including taxes, insurance and common area maintenance until December 31, 2020. Beginning January 1, 2021, the rent adjusted to $80,000 per month on a triple net basis and shall increase at an annual rate of 3% per annum until December 31, 2027.
Operating lease costs | $			$ 190,497	$ 271,542	$ 380,995	$ 533,910
Remaining lease term			42 months		42 months
Lease discount rate			7%		7%
Minimum
Lessee, Lease, Description [Line Items]
Net rentable area | ft²							75,000

OPERATING LEASE - Schedule of A

OPERATING LEASE - Schedule of Assets and Liabilities Related to Company's Lease (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Operating lease right-of-use assets, net	$ 2,129,854	$ 2,364,672
Current portion of operating lease liability	533,503	491,440
Non-current operating lease liabilities	$ 1,762,575	$ 2,043,025

OPERATING LEASE - Schedule Futu

OPERATING LEASE - Schedule Future Maturities of Operating Lease Liability (Details)	Jun. 30, 2024 USD ($)
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Remainder of 2024	$ 384,565
2025	792,203
2026	815,969
2027	840,449
Total lease payments	2,833,186
Less amounts representing interest	(537,108)
Present value of lease liability	$ 2,296,078

INVENTORIES - Schedule of Inven

INVENTORIES - Schedule of Inventories (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 460,165	$ 445,721
Work in process	691	1,775
Total	$ 460,856	$ 447,496

BRIDGE LOAN - Summary of Bridge

BRIDGE LOAN - Summary of Bridge Loan (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Apr. 02, 2024	Apr. 01, 2024
Short-Term Debt [Line Items]
Principal Payments	$ (560,756)
Ending, Principal Balance	637,751
Bridge Loans
Short-Term Debt [Line Items]
Beginning, Principal Balance	0
Bridge new loans	1,240,800
Principal Payments	(560,756)
Ending, Principal Balance	680,044
Discount	(42,293)	$ (20,800)	$ (20,800)
Bridge Loan, net of discount	$ 637,751

BRIDGE LOAN - Additional Inform

BRIDGE LOAN - Additional Information (Details)				3 Months Ended		6 Months Ended
	Apr. 17, 2024 USD ($)	Apr. 02, 2024 USD ($)	Feb. 27, 2024 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)	Apr. 01, 2024 USD ($) $ / shares
Short-Term Debt [Line Items]
Net proceeds						$ 1,153,750
Interest expense				$ 463	$ 746,578	463,397	$ 1,799,506
Bridge Loan
Short-Term Debt [Line Items]
Aggregate principal amount		$ 180,800		155,624		155,624		$ 180,800
Net proceeds		160,000
Total repayment		$ 202,496
Loans mature date		Jan. 01, 2025
Convertible discount rate		25
Lowest conversion price | $ / shares								$ 0.25
Interest payable				5,980		5,980
Interest expense						17,962
Original issuance discount		$ 20,800		42,293		$ 42,293		$ 20,800
Bridge Loan | Loan 1
Short-Term Debt [Line Items]
Aggregate principal amount			$ 375,000
Origination fees paid			25,000
Net proceeds			$ 350,000
Frequency of periodic payment			weekly
Weekly payments	$ 31,000		$ 19,420
Total repayment	993,250		543,750
Short-Term Debt, Terms						Under Loan 1, the Company will make weekly payments of $19,420 for 28 weeks for a total repayment of $543,750. The Company also had an early repayment option where the Company would repay an aggregate of $478,125 if repaid by April 15, 2024.
Payment for early extinguish of debt			$ 478,125
Bridge Loan | Loan 2
Short-Term Debt [Line Items]
Aggregate principal amount	685,000			524,420		$ 524,420
Origination fees paid	34,250
Net proceeds	$ 222,440
Frequency of periodic payment	weekly
Total repayment	$ 428,310
Interest payable				$ 5,452		5,452
Interest expense						$ 360,039

OTHER PAYABLE - Additional Info

OTHER PAYABLE - Additional Information (Details) - Unsecured Debt - Note Payable Conversion - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2017
Debt Instrument [Line Items]
Notes payable		$ 250,000
Stated interest rate		5%
Interest accrued on convertible debt	$ 87,568

CONVERTIBLE NOTES - Schedule of

CONVERTIBLE NOTES - Schedule of Convertible Notes (Details) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Jun. 30, 2024	Dec. 31, 2023
Debt Instrument, Principal [Roll Forward]
Notes converted	$ (1,279,782)	$ (400,000,000,000)
Net Principal Balance			$ 354,936
L1 Capital Global Opportunities Master Fund, Ltd
Debt Instrument, Principal [Roll Forward]
Principal Balance, beginning	$ 406,667	406,667
Notes converted		(400,000)
Notes paid		$ (6,667)

CONVERTIBLE NOTES - Additional

CONVERTIBLE NOTES - Additional Information (Details) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Short-Term Debt [Line Items]
Debt instrument converted amount		$ 1,279,782		$ 400,000,000,000
Debt conversion, converted instrument, shares issued		1,793,404		1,793,404
Conversion of stock shares				618,384
Interest expense upon conversion	$ 463		$ 746,578	$ 463,397	$ 1,799,506
Floor price				$ 0.65
Cash payable		$ 199,997
Amortization of debt discount				$ 64,017	1,542,085
Convertible Notes
Short-Term Debt [Line Items]
Amortization of debt discount	$ 397		$ 640,438	19,260	$ 1,542,097
L1 Capital Global Opportunities Master Fund, Ltd
Short-Term Debt [Line Items]
Debt instrument converted amount				$ 400,000

SERIES A PREFERRED STOCK - Addi

SERIES A PREFERRED STOCK - Additional Information (Details) - USD ($)		6 Months Ended
	Jan. 01, 2024	Jun. 30, 2024	Dec. 31, 2023
Series A Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares outstanding (in shares)	48,100	48,100	48,100
Preferred stock, dividend rate	8%
Preferred stock, dividend, make-whole dividend rate to market value	10%
Preferred stock, conversion, required common share price (in dollars per share)		$ 232
Preferred stock, conversion, required common share price, term		20 days
Preferred stock redemption price per share		$ 8
Accrued and unpaid dividends		$ 538,586
Common Stock | Maximum
Class Of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)		1

SERIES 1B PREFERRED STOCK - Add

SERIES 1B PREFERRED STOCK - Additional Information (Details)	6 Months Ended
	Jun. 30, 2024 $ / shares
Class of Stock [Line Items]
Floor price	$ 0.65

SERIES Z PREFERRED STOCK - Addi

SERIES Z PREFERRED STOCK - Additional Information (Details)	1 Months Ended
	Jul. 20, 2024 Vote shares	Jun. 30, 2024 $ / shares	Jun. 20, 2024 USD ($) $ / shares
Class of Stock [Line Items]
Preferred stock, par value (in dollars per share)		$ 0.0001
Series Z Preferred Stock | Securities Purchase Agreement
Class of Stock [Line Items]
Number of shares issued and sold | shares	1
Preferred stock, par value (in dollars per share)			$ 0.0001
Purchase price of share			$ 1,000
Redemption amount | $			$ 1,000
Preferred stock number of votes | Vote	180,000,000

STOCKHOLDERS' EQUITY (DEFICIT_2

STOCKHOLDERS' EQUITY (DEFICIT) - Additional Information (Details)

3 Months Ended

6 Months Ended

May 30, 2024 USD ($)

May 23, 2024 USD ($)

May 16, 2024 USD ($) $ / shares

Apr. 18, 2024 USD ($) $ / shares shares

Apr. 12, 2024 USD ($) $ / shares shares

Apr. 09, 2024 USD ($) $ / shares shares

Mar. 07, 2024 USD ($)

Mar. 06, 2024 USD ($)

Jun. 30, 2024 USD ($) $ / shares shares

Mar. 31, 2024 USD ($) $ / shares shares

Jun. 30, 2024 USD ($) Vote $ / shares shares

Dec. 31, 2023 $ / shares shares

Dec. 19, 2022 Investor

Class Of Stock [Line Items]

Common stock, shares authorized (in shares) | shares

500,000,000

500,000,000

500,000,000

Common stock, par value (in dollars per share) | $ / shares

$ 0.0001

$ 0.0001

$ 0.0001

Common stock, shares outstanding (in shares) | shares

98,825,076

98,825,076

3,583,846

Common stock, number of votes per share | Vote

1

Notes converted

$ (1,279,782)

$ (400,000,000,000)

Conversion of stock shares | shares

618,384

Conversions notes payable

$ 1,279,782

$ 1,279,782

Debt conversion, converted instrument, shares issued (in shares) | shares

1,793,404

1,793,404

Warrants expiring term

5 years 6 months

Warrant settlement expense

$ 743,459

$ 743,459

Outstanding common warrants | shares

11,877,142

11,877,142

Preferred stock, shares authorized (in shares) | shares

25,000,000

25,000,000

Preferred stock, par value (in dollars per share) | $ / shares

$ 0.0001

$ 0.0001

Aggregate gross proceeds

$ 12,796,460

Pre-funded warrants were exercised into common stock | shares

21,162,277

Purchase price for repurchase of warrants

$ 3,600,000

Common Stock

Class Of Stock [Line Items]

Common stock issued to settle liabilities (in shares) | shares

350,000

Minimum

Class Of Stock [Line Items]

Warrant exercise price per share | $ / shares

0.14

$ 0.14

Maximum

Class Of Stock [Line Items]

Warrant exercise price per share | $ / shares

1,060

$ 1,060

Prefunded warrants [Member]

Class Of Stock [Line Items]

Warrant exercise price per share | $ / shares

$ 0.0001

ATM Agreement [Member]

Class Of Stock [Line Items]

Common stock, par value (in dollars per share) | $ / shares

$ 0.0001

Aggregate gross proceeds

$ 8,960,000

Aggregate sales price of common stock

$ 3,981,000

$ 4,344,000

$ 4,219,000

Common stock shares issued | shares

55,342,643

Common stock price per share | $ / shares

$ 0.162

$ 0.162

Percentage of commission on aggregate gross proceeds

3%

Securities Purchase Contract

Class Of Stock [Line Items]

Warrants exercisable for number shares of common stock | shares

5,596,232

Warrant exercise price per share | $ / shares

$ 1.765

Number of institutional investors | Investor

2

Warrant Repurchase Agreements

Class Of Stock [Line Items]

Warrant exercise price per share | $ / shares

$ 0.14

Outstanding common warrants | shares

7,100,000

Agreement Entered Date

Mar. 07, 2024

Mar. 06, 2024

Gross proceeds from securities

$ 5,000,000

$ 5,000,000

Purchase price for repurchase of warrants

$ 3,600,000

$ 3,600,000

Warrant Repurchase Agreements | First Repurchase

Class Of Stock [Line Items]

Percentage of warrants investors agree to convey, assign and transfer

50%

Aggregate purchase price

$ 1,800,000

Warrant Repurchase Agreements | Second Repurchase

Class Of Stock [Line Items]

Aggregate purchase price for remaining warrants

$ 1,800,000

Placement Agent Agreement [Member]

Class Of Stock [Line Items]

Percentage of gross proceeds from sale of Units

4%

Placement Agent Agreement [Member] | Common Stock

Class Of Stock [Line Items]

Shares, Issued | shares

15,179,460

Placement Agent Agreement [Member] | Prefunded warrants [Member]

Class Of Stock [Line Items]

Prefunded warrants issued | shares

21,162,277

L1 Capital Global Opportunities Master Fund, Ltd

Class Of Stock [Line Items]

Payment of cash payable

$ 200,000

Dawson James [Member] | Placement Agent Agreement [Member]

Class Of Stock [Line Items]

Percentage of gross proceeds from sale of Units

8%

Proceeds from issuance or sale of equity

$ 5,090,000

Offering shares of common stock warrant to purchase

$ 6,000,000

Agreement Entered Date

Apr. 09, 2024

Dawson James [Member] | Placement Agent Agreement [Member] | Maximum

Class Of Stock [Line Items]

Offering expenses

$ 155,000

Sabby | L1 Capital Global Opportunities Master Fund, Ltd

Class Of Stock [Line Items]

Warrant exercise price per share | $ / shares

$ 1.765

Repurchase and cancel of warrants

$ 3,600,000

Outstanding common warrants | shares

5,596,232

Adjusted Number of Warrants | shares

70,554,495

Adjusted purchase of common stock exercise price | $ / shares

$ 0.14

STOCKHOLDERS' EQUITY (DEFICIT_3

STOCKHOLDERS' EQUITY (DEFICIT) - Schedule of Fair Value of Warrants (Details)	Jun. 30, 2024 yr
Expected Stock Price Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair value of warrants	154.5
Dividend Yield
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair value of warrants	0
Risk-free Interest Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair value of warrants	4.75
Expected Life of the Warrants (In Years)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair value of warrants	2.75

STOCKHOLDERS' EQUITY (DEFICIT_4

STOCKHOLDERS' EQUITY (DEFICIT) - Schedule of Stock by Class (Details) - shares	Jun. 30, 2024	Jan. 01, 2024	Dec. 31, 2023
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	25,000,000
Series A Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	750,000		750,000
Preferred stock, shares outstanding (in shares)	48,100	48,100	48,100
Series 1A Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	5,000
Preferred stock, shares outstanding (in shares)	0
Series B-1 Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	2,000
Preferred stock, shares outstanding (in shares)	0
Series B-2 Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	1,000
Preferred stock, shares outstanding (in shares)	0
Series 1B Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	900
Preferred stock, shares outstanding (in shares)	0
Series C Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	1,000
Preferred stock, shares outstanding (in shares)	0
Series D Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	3,000
Preferred stock, shares outstanding (in shares)	0
Series D-1 Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	2,500
Preferred stock, shares outstanding (in shares)	0
Series E Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	2,800
Preferred stock, shares outstanding (in shares)	0
Series F Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	7,000
Preferred stock, shares outstanding (in shares)	0
Series G Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	2,000
Preferred stock, shares outstanding (in shares)	0
Series H Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	2,500
Preferred stock, shares outstanding (in shares)	0
Series I Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	1,000
Preferred stock, shares outstanding (in shares)	0
Series J Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	1,350
Preferred stock, shares outstanding (in shares)	0
Series J-1 Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	1,000
Preferred stock, shares outstanding (in shares)	0
Series K Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	20,000
Preferred stock, shares outstanding (in shares)	0
Series Z Preferred Stock
Class Of Stock [Line Items]
Preferred stock, shares authorized (in shares)	1
Preferred stock, shares outstanding (in shares)	1

SHARE-BASED COMPENSATION - Addi

SHARE-BASED COMPENSATION - Additional Information (Details) - USD ($)	1 Months Ended	6 Months Ended
	Jan. 31, 2024	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares of restricted stock units granted		481,000
Number of unvested units		316,964		1,867
Number of forfeited shares		2,000
Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Total unrecognized share-based compensation expense		$ 1,220,860
Number of unvested units		316,964
Unrecognized share-based compensation expense, period for recognition		1 year 9 months
Fair value of shares on vesting dates		$ 61,563	$ 233,731
Employees and Directors | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares of restricted stock units granted	459,000
Employees and Directors | Restricted Stock Units | One Third
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting date	Mar. 31, 2024
Employees and Directors | Restricted Stock Units | Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting date	Jan. 01, 2025
Employees and Directors | Restricted Stock Units | Tranche Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting date	Jan. 01, 2026
Advisory Board | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares of restricted stock units granted	20,000
Advisory Board | Restricted Stock Units | Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting date	Jan. 01, 2025	Jun. 30, 2024
Advisory Board | Restricted Stock Units | Tranche Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting date	Jan. 01, 2026	Jan. 01, 2025

SHARE-BASED COMPENSATION - Summ

SHARE-BASED COMPENSATION - Summary of Non-vested Restricted Stock and Related Activity (Details)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning Balance, Non-vested Shares | shares	1,867
Shares granted | shares	481,000
Shares vested | shares	(163,903)
Shares forfeited | shares	(2,000)
Ending Balance, Non-vested Shares | shares	316,964
Non-vested, Weighted Average Grant Date Fair Value, Beginning Balance | $ / shares	$ 596
Weighted Average Grant Date Fair Value, Granted | $ / shares	0.76
Weighted Average Grant Date Fair Value, Vested | $ / shares	1.61
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	0.77
Non-vested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares	$ 5.06

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - Wainwright engagement letter [Member] $ / shares in Units, $ in Millions	Aug. 15, 2023 USD ($) $ / shares shares
Commitments And Contingencies [Line Items]
Percentage of fees payable under tail provision	8%
Percentage of warrant coverage on secured convertible note financing	7%
Secured convertible note financing	$ 15
Damages value	$ 1.2
Common stock warrants | shares	2,169.5
Warrant exercise price per share | $ / shares	$ 605

SUBSEQUENT EVENTS - Additional

SUBSEQUENT EVENTS - Additional Information (Details) - USD ($)		6 Months Ended
	Jul. 01, 2024	Jun. 30, 2024
Subsequent Event [Line Items]
Aggregate gross proceeds		$ 12,796,460
ATM Agreement
Subsequent Event [Line Items]
Number of shares sold		55,342,643
Average price per share		$ 0.162
Aggregate gross proceeds		$ 8,960,000
Subsequent Event | ATM Agreement | Common Stock
Subsequent Event [Line Items]
Number of shares sold	3,519,100
Average price per share	$ 0.113
Aggregate gross proceeds	$ 399,300